Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral and intravenous ascorbic acid effectiveness on erythropoietin-hyporesponsive anemia in hemodialysis patients
IRCT201306115864N3Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ascorbic acid in anaemia (2 arms), sponsored by Golestan University of Medical Sciences. Started Oct 2012; status: completed.
02
Drugs
ascorbic acid
03
Conditions
anaemia
Beyond the preview
Go deeper on IRCT201306115864N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201306115864N3.